About PipelineEvidence
A comprehensive oncology intelligence platform built to make cancer treatment information clear, accessible, and actionable.
Our Mission
Cancer treatment is evolving faster than ever. New drug approvals, combination regimens, and biomarker-driven therapies are transforming outcomes across dozens of tumor types — but keeping up with the pace of change is a challenge for everyone, from patients newly diagnosed to oncologists managing complex treatment decisions.
PipelineEvidence exists to centralize this information. We aggregate data from the FDA, EMA, ClinicalTrials.gov, NCI SEER, and peer-reviewed literature into a single, well-organized platform where anyone can find detailed, evidence-based information about approved cancer therapies.
Whether you are a patient researching your treatment options, a caregiver trying to understand what comes next, or a clinician reviewing the competitive landscape — PipelineEvidence is designed to give you the information you need, presented clearly and without spin.
The Platform at a Glance
Who PipelineEvidence Is For
Patients & Caregivers
Understanding your diagnosis and treatment options is empowering. PipelineEvidence gives you the same drug information that oncologists reference — indications, how the drug works, side effect profiles, and the clinical trials behind each approval — in a format designed to be readable without a medical degree.
Oncologists & Clinical Teams
Quick-reference drug profiles structured like a navigable package insert, with dosing protocols, adverse reaction incidence data, and direct ClinicalTrials.gov links. Use the comparison tool to evaluate therapies side by side.
Clinical Researchers
Identify pivotal trials by NCT number, review approved regimens across tumor types, and explore the active clinical pipeline. Each drug and tumor page links directly to ClinicalTrials.gov and PubMed.
Pharmaceutical & Biotech Professionals
Medical affairs, MSLs, and commercial teams use PipelineEvidence to map competitive landscapes, review standard-of-care protocols, and access structured drug intelligence across therapeutic areas.
What We Provide
131 Navigable Drug Profiles
Each entry is structured as a complete package insert — brand and generic names, drug class, mechanism of action, FDA-approved indications, dosing, adverse reactions with visual incidence charts, pharmacokinetics, pivotal trial data with registry links, and cross-referenced tumor types.
50 Tumor-Specific Pages
From lung cancer to Waldenström macroglobulinemia, each tumor page covers approved therapies organized by drug class, active clinical trial pipelines, molecular biology and biomarkers, SEER epidemiology, treatment landscape editorials, and structured FAQ sections.
Drug Comparison Tool
Compare any two approved therapies side by side across mechanism of action, indications, dosing, adverse reactions, pharmacokinetics, and pivotal trials. Try it now →
Educational Articles
In-depth guides on how to read Kaplan-Meier curves, understanding hazard ratios, PFS vs. OS endpoints, immunotherapy mechanisms, antibody-drug conjugates, and precision medicine. Browse articles →
SEER Cancer Statistics
Population-level incidence, mortality, 5-year survival by stage, demographic breakdowns, and temporal trends from the NCI SEER program for 26 major tumor types. All properly cited per NCI reuse policy.
Data Sources & Standards
Every data point on PipelineEvidence traces back to an authoritative primary source:
Prescribing information, approvals, label updates
US clinical trial registry with NCT numbers
European approvals and trial registry
Cancer statistics and epidemiology data
NEJM, Lancet Oncology, JCO, and others
Treatment guidelines and standards of care
Our complete editorial process, verification procedures, and quality standards are documented on the Methodology page.
Important Disclaimer
PipelineEvidence is designed as an informational and educational resource. It does not provide medical advice. The information on this platform should not be used as a substitute for consultation with qualified healthcare professionals. Treatment decisions should always be made in partnership with your oncology team, who can consider the full clinical context of your individual situation.
For our complete policies, please review our Medical Disclaimer, Terms of Use, and Privacy Policy.
Get in Touch
We welcome feedback, corrections, and suggestions from patients, clinicians, researchers, and industry professionals. If you identify an error or want to suggest an improvement, please visit our Contact page.
For partnership, sponsorship, or data licensing inquiries: info@pipelineevidence.com